NASDAQ: IOVAIovance Biotherapeutics Inc Stock Ownership - Who owns Iovance Biotherapeutics?
Insider buying vs selling
Have Iovance Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Frederick G. Vogt | Interim CEO General Counsel | 2024-04-15 | 8,851 | $11.89 | $105.24kSell |
| Igor Bilinsky | Chief Operating Officer | 2024-04-15 | 1,427 | $11.89 | $16.97kSell |
| Finckenstein Friedrich Graf | Chief Medical Officer | 2024-04-15 | 1,427 | $11.89 | $16.97kSell |
| Finckenstein Friedrich Graf | Chief Medical Officer | 2024-03-04 | 8,053 | $16.96 | $136.58kSell |
| Igor Bilinsky | Chief Operating Officer | 2024-03-04 | 7,287 | $16.96 | $123.59kSell |
| Frederick G. Vogt | Interim CEO General Counsel | 2024-03-04 | 11,449 | $16.96 | $194.18kSell |
| Merrill A. McPeak | Director | 2024-02-20 | 250,000 | $9.15 | $2.29MBuy |
| Iain D. Dukes | Director | 2024-02-20 | 32,000 | $9.15 | $292.80kBuy |
| Wayne P. Rothbaum | Director | 2024-02-20 | 5,000,000 | $9.15 | $45.75MBuy |
| Igor Bilinsky | Chief Operating Officer | 2024-01-16 | 1,577 | $8.37 | $13.20kSell |
IOVA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IOVA insiders and whales buy or sell their stock.
IOVA Shareholders
What type of owners hold Iovance Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ayer Capital Management LP | 201.65% | 563,224,483 | $6.38B | Insider |
| Paul L. Kessler | 148.78% | 415,566,430 | $4.70B | Insider |
| Wayne P. Rothbaum | 10.05% | 28,067,333 | $317.72M | Insider |
| Vanguard Group Inc | 8.17% | 22,812,820 | $258.24M | Institution |
| Atlantic Hamilton | 7.50% | 20,960,016 | $237.27M | Insider |
| Mhr Fund Management LLC | 7.16% | 19,997,103 | $226.37M | Institution |
| Blackrock Inc | 6.83% | 19,071,756 | $215.89M | Institution |
| David J. Voyticky | 6.80% | 18,981,082 | $214.87M | Insider |
| State Street Corp | 5.88% | 16,424,388 | $185.92M | Institution |
| Sanford Hillsberg | 4.83% | 13,500,000 | $152.82M | Insider |
IOVA vs Biotech Stocks
Iovance Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.